Correlation Between Unicycive Therapeutics and Bicycle Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Bicycle Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Bicycle Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Bicycle Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Bicycle Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Bicycle Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Bicycle Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Bicycle Therapeutics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Unicycive and Bicycle is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Bicycle Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bicycle Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Bicycle Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bicycle Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Bicycle Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Bicycle Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 2.05 times more return on investment than Bicycle Therapeutics. However, Unicycive Therapeutics is 2.05 times more volatile than Bicycle Therapeutics. It trades about 0.23 of its potential returns per unit of risk. Bicycle Therapeutics is currently generating about -0.13 per unit of risk. If you would invest 38.00 in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of 42.00 from holding Unicycive Therapeutics or generate 110.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Bicycle Therapeutics
Performance |
| Timeline |
| Unicycive Therapeutics |
| Bicycle Therapeutics |
Unicycive Therapeutics and Bicycle Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Bicycle Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Bicycle Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Bicycle Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bicycle Therapeutics will offset losses from the drop in Bicycle Therapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Bicycle Therapeutics vs. Ideaya Biosciences | Bicycle Therapeutics vs. AnaptysBio | Bicycle Therapeutics vs. MeiraGTx Holdings PLC | Bicycle Therapeutics vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |